INSPIRE MEDICAL SYSTEMS INC (INSP) Forecast, Price Target & Analyst Ratings

NYSE:INSP • US4577301090

62.99 USD
+0.53 (+0.85%)
At close: Mar 6, 2026
62.99 USD
0 (0%)
After Hours: 3/6/2026, 8:27:03 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for INSPIRE MEDICAL SYSTEMS INC (INSP).

Forecast Snapshot

Consensus Price Target

Price Target
$95.55
+ 51.69% Upside

Next Earnings Forecast

Earnings Estimate
Release DateMay 4, 2026
PeriodQ1 / 2026
EPS Estimate-$0.23
Revenue Estimate208.26M

ChartMill Buy Consensus

Rating
76.80%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$95.55
Upside
+ 51.69%
From current price of $62.99 to mean target of $95.55, Based on 25 analyst forecasts
Low
$60.60
Median
$81.60
High
$189.00

Price Target Revisions

1 Month
-33.08%
3 Months
-16.18%

Price Target Summary

25 analysts have analysed INSP and the average price target is 95.55 USD. This implies a price increase of 51.69% is expected in the next year compared to the current price of 62.99.
The average price target has been revised downward by 16.18% in the past 3 months.
 → Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

INSP Current Analyst RatingINSP Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

INSP Historical Analyst RatingsINSP Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20 25

Analyst Ratings Consensus

ChartMill Buy Consensus
76.80%
INSP was analyzed by 25 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about INSP.
In the previous month the buy percentage consensus was at a similar level.
INSP was analyzed by 25 analysts, which is quite many. So the average rating should be quite meaningful.
 → Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-05StifelMaintains Buy -> Buy
2026-02-13Wolfe ResearchDowngrade Outperform -> Peer Perform
2026-02-12MizuhoMaintains Outperform -> Outperform
2026-02-12RBC CapitalMaintains Sector Perform -> Sector Perform
2026-02-12Wells FargoDowngrade Overweight -> Equal-Weight
2026-02-12Truist SecuritiesMaintains Hold -> Hold
2026-02-12BairdDowngrade Outperform -> Neutral
2026-02-12Piper SandlerMaintains Overweight -> Overweight
2026-02-12JefferiesMaintains Hold -> Hold
2026-01-27RBC CapitalDowngrade Outperform -> Sector Perform
2026-01-14Wells FargoMaintains Overweight -> Overweight
2026-01-08Truist SecuritiesMaintains Buy -> Buy
2025-12-23UBSMaintains Neutral -> Neutral
2025-12-17MizuhoMaintains Outperform -> Outperform
2025-12-17RBC CapitalMaintains Outperform -> Outperform
2025-12-16JP MorganMaintains Neutral -> Neutral
2025-12-08OppenheimerUpgrade Perform -> Outperform
2025-12-08Piper SandlerMaintains Overweight -> Overweight
2025-12-04BairdMaintains Outperform -> Outperform
2025-12-02Morgan StanleyDowngrade Overweight -> Equal-Weight
2025-11-26Truist SecuritiesUpgrade Hold -> Buy
2025-11-25Wolfe ResearchUpgrade Peer Perform -> Outperform
2025-11-24StifelUpgrade Hold -> Buy
2025-11-04RBC CapitalMaintains Outperform -> Outperform
2025-11-04Wells FargoUpgrade Equal-Weight -> Overweight

Next Earnings Forecast Details

Next Earnings Details

Release DateMay 4, 2026
PeriodQ1 / 2026
EPS Estimate-$0.23
Revenue Estimate208.26M
Revenue Q2Q3.45%
EPS Q2Q-328.35%
Number of Analysts18

Next Earnings Revisions

Revenue (1 Month)
0.14%
Revenue (3 Months)
1.04%
EPS (1 Month)
0.27%
EPS (3 Months)
30.36%

Next Earnings Summary

INSP is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is -0.23 USD and the consensus revenue estimate is 208.26M USD.
The next earnings revenue estimate has been revised upward by 1.04% in the past 3 months.
 → Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
INSP revenue by date.INSP revenue by date.
624.799M
53.17%		802.804M
28.49%		911.981M
13.60%		991.28M
8.70%		1.081B
9.05%		1.207B
11.66%		1.367B
13.26%		1.51B
10.46%		1.587B
5.10%		1.788B
12.67%		1.906B
6.60%
EBITDA
YoY % growth
INSP ebitda by date.INSP ebitda by date.
-37.425M
18.18%		42.633M
213.92%		N/A
328.80%		226.99M
24.17%		266.98M
17.62%		267.78M
0.30%		338.64M
26.46%		393.41M
16.17%		439.42M
11.70%		N/AN/A
EBIT
YoY % growth
INSP ebit by date.INSP ebit by date.
-40.271M
15.40%		36.083M
189.60%		50.954M
41.21%		63.424M
24.47%		85.631M
35.01%		116.16M
35.65%		149.46M
28.67%		197.3M
32.01%		310.44M
57.34%		505.92M
62.97%		601.8M
18.95%
Operating Margin
INSP operating margin by date.INSP operating margin by date.
-6.45%4.49%5.59%6.40%7.92%9.62%10.93%13.07%19.56%28.30%31.57%
EPS
YoY % growth
INSP eps by date.INSP eps by date.
-0.74
54.88%		1.73
333.78%		2.51
45.09%		1.76
-29.76%		2.57
45.56%		3.50
36.58%		4.06
15.74%		4.93
21.58%		5.06
2.59%		N/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.23
-328.35%		0.30
-33.49%		0.44
30.84%		0.80
-50.57%		0.35
251.87%		0.42
39.72%		0.48
7.76%		0.58
-28.03%
Revenue
Q2Q % growth		208.26M
3.45%		235.92M
8.68%		255.22M
13.68%		300.19M
11.56%		263.32M
26.44%		279.69M
18.55%		288.43M
13.01%		318.81M
6.20%
EBITDA
Q2Q % growth		24.784M
1,489.74%		51.398M
1,535.84%		52.978M
167.85%		70.914M
21.74%		52.02M
109.89%		52.02M
1.21%		53.04M
0.12%		53.04M
-25.21%
EBIT
Q2Q % growth		-12.573M
-746.63%		7.916M
338.72%		13.435M
39.31%		31.965M
-30.68%		10.547M
183.89%		13.841M
74.85%		16.55M
23.19%		20.864M
-34.73%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

INSP Yearly Revenue VS EstimatesINSP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B
INSP Yearly EPS VS EstimatesINSP Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 -2 4 -4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
11.77%
EPS Next 5 Year
14.46%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
9.22%
Revenue Next 5 Year
10.27%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
109.90%
EBIT Next 5 Year
68.51%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

INSPIRE MEDICAL SYSTEMS INC / INSP Forecast FAQ

What is the average price target for INSPIRE MEDICAL SYSTEMS INC (INSP) stock?

25 analysts have analysed INSP and the average price target is 95.55 USD. This implies a price increase of 51.69% is expected in the next year compared to the current price of 62.99.


Can you provide the upcoming earnings date for INSPIRE MEDICAL SYSTEMS INC?

INSPIRE MEDICAL SYSTEMS INC (INSP) will report earnings on 2026-05-04, after the market close.


What are the consensus estimates for INSPIRE MEDICAL SYSTEMS INC (INSP) next earnings?

The consensus EPS estimate for the next earnings of INSPIRE MEDICAL SYSTEMS INC (INSP) is -0.23 USD and the consensus revenue estimate is 208.26M USD.


What is the expected long term growth rate for INSPIRE MEDICAL SYSTEMS INC (INSP)?

The expected long term growth rate for INSPIRE MEDICAL SYSTEMS INC (INSP) is 9.22%.